Literature DB >> 8797483

The outcome of absence epilepsy: a meta-analysis.

P A Bouma1, R G Westendorp, J G van Dijk, A C Peters, O F Brouwer.   

Abstract

We performed a meta-analysis of studies on absence epilepsy (AE) to ascertain whether the outcome of this well-defined type of epilepsy can be stated unequivocally. Using the Index Medicus and Medline CD+, we identified 1,619 publications. After applying the criteria of the International League against Epilepsy (ILAE) for AE, 26 publications on 23 study cohorts with a total of 2,303 patients were included. Remission rates ranged from 0.21 to 0.89; they differed substantially due to heterogeneity between the studies in inclusion criteria, methods, follow-up length, and outcome definitions. One half of the patients developed generalized tonic-clonic seizures (TCS) in the course of the disease. The proportion seizure free was 0.78 for patients with absence seizures (AS) only, and 0.35 for those who developed TCS. The outcome of AE may be worse than previously stated due to the considerable proportion of patients developing TCS in the course of their disease. Early prediction of outcome in patients who present with AS cannot be provided with certainty.

Entities:  

Mesh:

Year:  1996        PMID: 8797483     DOI: 10.1212/wnl.47.3.802

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Genetic evaluation and counseling for epilepsy.

Authors:  Deb K Pal; Amanda W Pong; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2010-07-20       Impact factor: 42.937

2.  Familial clustering of seizure types within the idiopathic generalized epilepsies.

Authors:  M R Winawer; C Marini; B E Grinton; D Rabinowitz; S F Berkovic; I E Scheffer; R Ottman
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

3.  Polyspike and waves do not predict generalized tonic-clonic seizures in childhood absence epilepsy.

Authors:  Esther Vierck; Ryan Cauley; Steven L Kugler; David E Mandelbaum; Deb K Pal; Martina Durner
Journal:  J Child Neurol       Date:  2010-04       Impact factor: 1.987

Review 4.  Driving status of patients with generalized spike-wave on EEG but no clinical seizures.

Authors:  Prince Antwi; Ece Atac; Jun Hwan Ryu; Christopher Andrew Arencibia; Shiori Tomatsu; Neehan Saleem; Jia Wu; Michael J Crowley; Barbara Banz; Federico E Vaca; Heinz Krestel; Hal Blumenfeld
Journal:  Epilepsy Behav       Date:  2018-12-21       Impact factor: 2.937

5.  Convulsive activity in the electroencephalogram in rats sensitive and tolerant to pentylenetetrazol kindling.

Authors:  T V Pavlova; G N Fesenko; A B Gekht; N V Gulyaeva; V M Koval'zon
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

6.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Peter C Adamson
Journal:  Epilepsia       Date:  2012-11-21       Impact factor: 5.864

Review 7.  Treatment of typical absence seizures and related epileptic syndromes.

Authors:  C P Panayiotopoulos
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  Selecting anti-epileptic drugs: a pediatric epileptologist's view, a computer's view.

Authors:  J Pestian; P Matykiewicz; K Holland-Bouley; S Standridge; M Spencer; T Glauser
Journal:  Acta Neurol Scand       Date:  2012-09-23       Impact factor: 3.209

9.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Edmund V Capparelli; Peter C Adamson
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

10.  Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome.

Authors:  Dennis Dlugos; Shlomo Shinnar; Avital Cnaan; Fengming Hu; Solomon Moshé; Eli Mizrahi; David Masur; Yoshi Sogawa; J B Le Pichon; Calley Levine; Deborah Hirtz; Peggy Clark; Peter C Adamson; Tracy Glauser
Journal:  Neurology       Date:  2013-05-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.